Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome – system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma.
Several years of research in Nielsen lab at Chalmers University of Technology in Gothenburg, Sweden led to the founding of Elypta in May 2017 by Francesco Gatto and Jens Nielsen.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Nanna Svartz Väg 4, Solna,stockholm County 171 65,sweden
- Phone
- +46 0 852 027 885
- in****@****pta.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- elypta.com
- Keywords
- diagnostics, biomarkers, cancer, oncology, urology, liquid biopsy, renal cell carcinoma, multi-cancer early detection, systems biology.
- HQ
- Solna, Stockholm County
Elypta Questions
Elypta's helpline number is +46 0 852 027 885
Elypta's website is elypta.com
Elypta's LinkedIn profile is https://se.linkedin.com/company/elypta
Elypta has
29 employees.
View email and phone details for 29
employees at Elypta.
Elypta's industry is
Biotechnology Research
Elypta's top competitors are
Algodx,
Arguseye,
Modvion,
Amferia Kills Bacteria,
Envue Technologies,
Pixelgen Technologies,
Bioinnovation Institute,
Industrifonden,
Asgard Therapeutics,
Capitainer.
Elypta's support email address is info@elypta.com
Elypta's categories are Biotechnology Research
Elypta's founding year is 2017
